Search results for "hepatitis"
Patients had high adherence to HCV treatment delivered in opioid agonist therapy programs
The hepatitis C virus (HCV) treatment completion rate was 97% among all participants, including those actively using drugs.
https://gastroenterology.acponline.org/archives/2019/04/26/6.htm
26 Apr 2019
Spotlight on The Liver Meeting
Highlights from the American Association for the Study of Liver Diseases' annual meeting, held virtually this past weekend, included insights on COVID-19 and the liver and a conversation with the winners of the Nobel Prize in Physiology or Medicine 2020, who discovered hepatitis C virus.
https://gastroenterology.acponline.org/archives/2020/11/20/5.htm
20 Nov 2020
Spotlight on direct-acting antivirals
Studies of contemporary populations with hepatitis C virus infection demonstrated that treatment with direct-acting antiviral therapies was linked to improvement in several long-term clinical outcomes.
https://gastroenterology.acponline.org/archives/2019/02/22/5.htm
22 Feb 2019
High HCV cure rate seen with FDA-approved direct-acting antiviral regimens
Six of the direct-acting antiviral (DAA) regimens yielded sustained virologic response rates above 95% in patients who had hepatitis C virus (HCV) genotype 1 without cirrhosis, including those with HIV co-infection.
https://gastroenterology.acponline.org/archives/2017/03/24/7.htm
24 Mar 2017
HCV-infected kidney transplants appear cost-effective in recipients with HCV
Transplanting a hepatitis C virus (HCV)-infected kidney and then administering HCV treatment was more effective and cost less than transplanting an HCV-uninfected kidney after HCV treatment in HCV-infected patients, mainly because the waiting list for uninfected kidneys is longer.
https://gastroenterology.acponline.org/archives/2018/07/27/6.htm
27 Jul 2018
Rise in liver disease deaths not fully explained by metabolic syndrome or alcohol use
An analysis of the prevalence of metabolic syndrome and alcohol use in the U.S. between 1999 and 2018 found that while the proportion of patients with metabolic syndrome and nonheavy alcohol use grew the most, liver disease increased the most among those who drank heavily.
https://gastroenterology.acponline.org/archives/2023/05/26/3.htm
26 May 2023
HCV treatment was successful among patients who used injection drugs
The open-label, single-arm, industry-funded phase 4 trial included patients who had used injection drugs within six months and had chronic hepatitis C virus (HCV), recruited at 19 sites in seven countries.
https://gastroenterology.acponline.org/archives/2018/01/26/2.htm
26 Jan 2018
U.S. sees decrease in HCC disease burden
Incidence of hepatocellular carcinoma (HCC) decreased sharply by 2.3% annually after 2011, while incidence-based mortality saw a 3.2% annual decrease after 2013, according to a study based on national data.
https://gastroenterology.acponline.org/archives/2022/02/25/2.htm
25 Feb 2022
Aspirin use is associated with reduced risk for hepatocellular carcinoma
The findings of a recent meta-analysis provide support for an association between aspirin use and reduced risk for hepatocellular carcinoma but do not warrant use of aspirin as prophylaxis, and more research is needed, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2022/07/22/8.htm
22 Jul 2022
MKSAP Quiz: Management of HBV infection
This month's quiz asks readers to determine the most appropriate next step in management of a 29-year-old woman with hepatitis B virus (HBV) infection and normal liver enzyme levels.
https://gastroenterology.acponline.org/archives/2021/04/23/4.htm
23 Apr 2021